Reports for HYDROCHLOROTHIAZIDE

Ingredient

HYDROCHLOROTHIAZIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
INHIBACE PLUS 5MG 12.5MG TABLET Resolved 2021-01-04 2021-10-19 130792
INHIBACE PLUS 12.5MG 5MG TABLET Resolved 2022-05-09 2022-05-25 160204
INHIBACE PLUS 12.5MG 5MG TABLET Resolved 2022-08-17 2022-09-30 166884
INHIBACE PLUS 12.5MG 5MG TABLET Resolved 2024-06-17 2024-10-19 230712
IRBESARTAN HCT 12.5MG 150MG TABLET Resolved 2019-04-01 2019-05-06 80252
IRBESARTAN HCT 150MG 12.5MG TABLET Resolved 2020-10-16 2021-02-12 126600
IRBESARTAN HCT 12.5MG 300MG TABLET Resolved 2018-11-12 2018-12-29 66698
IRBESARTAN HCT 12.5MG 300MG TABLET Resolved 2019-04-22 2019-06-22 82135
IRBESARTAN HCT 300MG 12.5MG TABLET Resolved 2020-10-16 2021-02-12 126603
IRBESARTAN HCT 300MG 25MG TABLET Resolved 2020-10-16 2021-02-12 126606

Showing 251 to 260 of 733

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RAMIPRIL-HCTZ 25.0MG 10.0MG TABLET Discontinued 2019-04-10 2019-04-11 81151
TELMISARTAN-HCTZ 25MG 80MG TABLET Discontinued 2017-10-12 2017-10-17 25720
TELMISARTAN-HCTZ 12.5MG 80MG TABLET Discontinued 2017-10-12 2017-10-17 25724
TEVA-IRBESARTAN HCTZ 300MG 25MG TABLET Discontinued 2024-06-28 2024-06-29 231580
TEVA-IRBESARTAN HCTZ 300MG 12.5MG TABLET Discontinued 2024-06-28 2024-06-29 231577
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 10MG TABLET Discontinued 2018-10-12 2018-10-12 63975
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81301
TEVA-LISINOPRIL/HCTZ (TYPE P) 25MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81368
TEVA-LOSARTAN/HCTZ 100MG 12.5MG TABLET Discontinued 2021-02-12 2021-02-12 133896
TEVA-LOSARTAN/HCTZ 50.0MG 12.5MG TABLET Discontinued 2021-02-12 2021-02-12 133902

Showing 91 to 100 of 110